Clinical trial
Patient Reported Symptom Control With THC or CBD Use
NCT04875286 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient Reported Symptom Control With THC or CBD Use
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- February 3, 2021
- Completion date
- February 2, 2027
- Enrollment
- 200 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cancer-associated pain, hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm